Immune-related adverse events with other cancer immunotherapies

Sebastian Bruera; Cerena K. Leung

doi:10.1007/978-3-030-56824-5_11

Immune-related adverse events with other cancer immunotherapies

Sebastian Bruera, Cerena K. Leung

Hospital Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

In addition to immune checkpoint inhibitors, several other forms of immunotherapy have been used to treat malignancies, some for decades. Furthermore, there have been other advances in the field with novel treatments that target the immune system in different ways, including adoptive cell transfer, cytokine therapy, and vaccines. In this chapter, we review the common immune-related adverse events associated with anti-neoplastic immunotherapy. We also discuss the severity of patients' symptoms and current treatments available to address these adverse events.

Original language	English (US)
Title of host publication	Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy
Subtitle of host publication	A Handbook for Diagnosis and Management
Publisher	Springer International Publishing
Pages	255-269
Number of pages	15
ISBN (Electronic)	9783030568245
ISBN (Print)	9783030568238
DOIs	https://doi.org/10.1007/978-3-030-56824-5_11
State	Published - Feb 16 2021

Keywords

BCG
Cancer immunotherapy
CAR-T
Immune-related adverse events
Interferon
Interleukin-2
Sipuleucel-T

ASJC Scopus subject areas

General Medicine
General Immunology and Microbiology

Access to Document

10.1007/978-3-030-56824-5_11

Cite this

@inbook{537811044913471eb12131eaa3c2f33c,

title = "Immune-related adverse events with other cancer immunotherapies",

abstract = "In addition to immune checkpoint inhibitors, several other forms of immunotherapy have been used to treat malignancies, some for decades. Furthermore, there have been other advances in the field with novel treatments that target the immune system in different ways, including adoptive cell transfer, cytokine therapy, and vaccines. In this chapter, we review the common immune-related adverse events associated with anti-neoplastic immunotherapy. We also discuss the severity of patients' symptoms and current treatments available to address these adverse events.",

keywords = "BCG, Cancer immunotherapy, CAR-T, Immune-related adverse events, Interferon, Interleukin-2, Sipuleucel-T",

author = "Sebastian Bruera and Leung, {Cerena K.}",

year = "2021",

month = feb,

day = "16",

doi = "10.1007/978-3-030-56824-5_11",

language = "English (US)",

isbn = "9783030568238",

pages = "255--269",

booktitle = "Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Immune-related adverse events with other cancer immunotherapies

AU - Bruera, Sebastian

AU - Leung, Cerena K.

PY - 2021/2/16

Y1 - 2021/2/16

N2 - In addition to immune checkpoint inhibitors, several other forms of immunotherapy have been used to treat malignancies, some for decades. Furthermore, there have been other advances in the field with novel treatments that target the immune system in different ways, including adoptive cell transfer, cytokine therapy, and vaccines. In this chapter, we review the common immune-related adverse events associated with anti-neoplastic immunotherapy. We also discuss the severity of patients' symptoms and current treatments available to address these adverse events.

AB - In addition to immune checkpoint inhibitors, several other forms of immunotherapy have been used to treat malignancies, some for decades. Furthermore, there have been other advances in the field with novel treatments that target the immune system in different ways, including adoptive cell transfer, cytokine therapy, and vaccines. In this chapter, we review the common immune-related adverse events associated with anti-neoplastic immunotherapy. We also discuss the severity of patients' symptoms and current treatments available to address these adverse events.

KW - BCG

KW - Cancer immunotherapy

KW - CAR-T

KW - Immune-related adverse events

KW - Interferon

KW - Interleukin-2

KW - Sipuleucel-T

UR - http://www.scopus.com/inward/record.url?scp=85149190711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149190711&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-56824-5_11

DO - 10.1007/978-3-030-56824-5_11

M3 - Chapter

AN - SCOPUS:85149190711

SN - 9783030568238

SP - 255

EP - 269

BT - Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy

PB - Springer International Publishing

ER -

Immune-related adverse events with other cancer immunotherapies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this